Skip to Main Content


We are CURRENTLY ENROLLING in the below trial for post COVID-19 Pneumonia.

LYT-100 in Post-acute COVID-19 Respiratory Disease
If this describes you, you may be a candidate for the above-mentioned trial.
  • between the ages of 18 and 80
  • suffered respiratory complications associated with COVID-19
  • Diagnosed with COVID-19 in the past 132 days
  • Hospitalized for at least 1 day and treated with a form of oxygen or breathing support

Contact Us Now



STILL TO COME...Long-hauler COVID trial

If you were diagnosed with COVID and continue to have symptoms 12 weeks later, then you may be considered a “long-hauler.”  Some of the symptoms may include but are not limited to:  brain fog or a hard time concentrating, forgetfulness, fatigue, muscle aches/cramps, joint pain, exertional malaise, cough, insomnia or sleep disturbances.  Some long-haulers have lingering respiratory symptoms such as shortness of breath and damage to their lungs due to COVID pneumonia. These symptoms can range from mild to severe. 

There is estimated to be 300 million people affected by COVID-19 around the world and from that 3 million people will have long-term effects of COVID-19.

Are you a long-hauler COVID patient?

Take a few moments to ask yourself the following questions:

  1. Were you previously diagnosed with COVID-19?
  2. Are you more than 12 weeks from when symptoms began?
  3. Are you still feeling the lingering effects of COVID-19?

We are planning for another long-hauler COVID trial focusing on neurological effects.   There will be more information to come.   Please let Tina know by filling out the contact form, noting you are interested in learning more.